Bio-Mimetics is suing Columbia Labs. for correction of inventorship, breach of contract, and unfair trade practices. The parties cross-moved for summary judgment.
Bio-Mimetics entered into an agreement with Columbia in 1989 which called for asset purchases, a license, and options to a patent and technology originally developed by Bio-Mimetics’ founder. Several years into the agreement Columbia exercised an option to purchase further interests in the patent. Following the expiration of the patent, the parties dispute the ongoing royalties due, with Columbia saying none because of the expiration and Bio-Mimetics saying that royalties need to continue until they hit a predetermined ceiling.
Judge Stearns interpreted the contract and found that neither one was exactly right. He found that the ongoing royalties depend on whether Columbia’s later patents should be considered “improvements” based on Bio-Mimetics’ patent, a question he left for the jury. Also, because there is no evidence that the original inventor of the Bio-Mimetics patent collaborated with the Columbia inventors, summary judgment for defendant Columbia was granted with respect to the claims for correction of inventorship of Columbia's patents and the related unfair trade practices claim.
Remaining issues set for trial July 12, 2010.
This case was decided prior to the Federal Circuit’s recent decision on joint inventorship in Vanderbilt Univ. v. ICOS Corp., 2009-1258 (Fed. Cir. Apr. 7, 2010), but there is nothing in Vanderbilt to suggest Judge Stearns’ decision was incorrect.
http://pacer.mad.uscourts.gov/dc/cgi-bin/recentops.pl?filename=stearns/pdf/biomimeticssj.pdf
Bio-Mimetics, Inc. v. Columbia Labs., Inc. 07-12389-RGS (D. Mass. Mar. 31, 2010)